Sign In
Buy AGYTF
$0.130
+0 (+0%)
At Close: Jun 03, 2026
Amazon and Delta announce agreement to offer improved in-flight Wifi
08:46am, Tuesday, 31'st Mar 2026
Amazon.com Inc (NASDAQ:AMZN) and Delta Air Lines Inc (NYSE:DAL) have announced a new multi-year agreement aimed at enhancing in-flight internet connectivity...
Grassmuno rollout to put Allergy Therapeutics on path to sustainable profitability, says broker
07:45am, Tuesday, 31'st Mar 2026
A successful rollout of its newly launched grass-pollen treatment is ste put Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) on the path to...
Grassmuno rollout to put Allergy Therapeutics on path to sustainable profitability, says broker
06:47am, Tuesday, 31'st Mar 2026
A successful rollout of its newly launched grass-pollen treatment is ste put Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) on the path to self-sustaining profitability. That's according to Ca
Allergy Therapeutics targets accelerating Grassmuno sales as peanut vaccine advances to next trial phase
04:34am, Tuesday, 31'st Mar 2026
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the immunotherapy company, expects commercial momentum to build through the second half of its financial year as its newly launched Grassmuno g
Dow set to jump as easing Middle East tensions lift Wall Street futures
04:18am, Tuesday, 31'st Mar 2026
8:15am: Cooling tensions US stocks were set for a strong open on Tuesday as easing geopolitical tensions lifted sentiment. Dow Jones and S&P 500 futures...
General Mills recovery likely multiyear, Jefferies says
10:11am, Wednesday, 04'th Mar 2026
General Mills Inc (NYSE:GIS, XETRA:GRM) shares remain under pressure as it faces continued volume declines in North America Retail (NAR) and limited...
Allergy Therapeutics peanut vaccine shows strong immune response in early trial
02:48am, Wednesday, 04'th Mar 2026
AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed allergy
Allergy Therapeutics peanut vaccine shows strong immune response in early trial
02:25am, Wednesday, 04'th Mar 2026
AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY,...
Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes
02:30am, Thursday, 26'th Feb 2026
The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed biotechn
Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes
02:26am, Thursday, 26'th Feb 2026
The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY,...
Lululemon price target slashed on outgoing CEO’s final day
07:51am, Friday, 30'th Jan 2026
Jefferies analysts lowered their price target on Lululemon Athletica Inc (NASDAQ:LULU) stock to $185 from $200, coinciding with the outgoing CEO Calvin...
FTSE 100 Live: London stocks recover as markets await Fed chair nomination
05:25am, Friday, 30'th Jan 2026
FTSE 100 gains 13 points to 10,185 Gold, silver and copper retreat from recent highs Fed chair nomination expected today US index futures sink 10.25am:...
Allergy Therapeutics announces new management hires as it looks to Hong Kong
04:21am, Friday, 30'th Jan 2026
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has strengthened its management team, appointing Helge Weiner-Trapness as its new chief strategy officer and executive director. The newly create
Allergy Therapeutics announces new management hires as it looks to Hong Kong
04:06am, Friday, 30'th Jan 2026
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has strengthened its management team, appointing Helge Weiner-Trapness as its new chief strategy...
Allergy Therapeutics update receives broker seal of approval
07:35am, Monday, 19'th Jan 2026
Cavendish has reaiterated its 'buy' on shares in Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) pointing to early revenue growth and the start of commercial sales of the company's newly appro
